ADA1, a novel component of the ADA/GCN5 complex, has broader effects than GCN5, ADA2, or ADA3
dc.contributor.author | Horiuchi, Junjiro | |
dc.contributor.author | Silverman, Neal S. | |
dc.contributor.author | Pina, Benjamin | |
dc.contributor.author | Marcus, Gregory A. | |
dc.contributor.author | Guarente, Leonard | |
dc.date | 2022-08-11T08:09:09.000 | |
dc.date.accessioned | 2022-08-23T16:19:15Z | |
dc.date.available | 2022-08-23T16:19:15Z | |
dc.date.issued | 1997-06-01 | |
dc.date.submitted | 2009-12-15 | |
dc.identifier.citation | Mol Cell Biol. 1997 Jun;17(6):3220-8. <a href="http://mcb.asm.org/cgi/reprint/17/6/3220">Link to article on publisher's site</a> | |
dc.identifier.issn | 0270-7306 (Print) | |
dc.identifier.pmid | 9154821 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/35001 | |
dc.description.abstract | The ADA genes encode factors which are proposed to function as transcriptional coactivators. Here we describe the cloning, sequencing, and initial characterization of a novel ADA gene, ADA1. Similar to the previously isolated ada mutants, ada1 mutants display decreases in transcription from various reporters. Furthermore, ADA1 interacts with the other ADAs in the ADA/GCN5 complex as demonstrated by partial purification of the complex and immunoprecipitation experiments. We estimate that the complex has a molecular mass of approximately 2 MDa. Previously, it had been demonstrated that ada5 mutants displayed more severe phenotypic defects than the other ada mutants (G. A. Marcus, J. Horiuchi, N. Silverman, and L. Guarente, Mol. Cell. Biol. 16:3197-3205, 1996; S. M. Roberts and F. Winston, Mol. Cell. Biol. 16:3206-3213, 1996). ada1 mutants display defects similar to those of ada5 mutants and different from those of the other mutants with respect to promoters affected, inositol auxotrophy, and Spt- phenotypes. Thus, the ADAs can be separated into two classes, suggesting that the ADA/GCN5 complex may have two separate functions. We present a speculative model on the possible roles of the ADA/GCN5 complex. | |
dc.language.iso | en_US | |
dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=9154821&dopt=Abstract">Link to Article in PubMed</a> | |
dc.relation.url | http://mcb.asm.org/cgi/reprint/17/6/3220 | |
dc.subject | Acetylation | |
dc.subject | Blotting, Western | |
dc.subject | Cloning, Molecular | |
dc.subject | DNA, Fungal | |
dc.subject | DNA-Binding Proteins | |
dc.subject | Fungal Proteins | |
dc.subject | Histone Acetyltransferases | |
dc.subject | Histones | |
dc.subject | Inositol | |
dc.subject | Macromolecular Substances | |
dc.subject | Molecular Sequence Data | |
dc.subject | Phenotype | |
dc.subject | Protein Kinases | |
dc.subject | Saccharomyces cerevisiae | |
dc.subject | *Saccharomyces cerevisiae Proteins | |
dc.subject | Sequence Analysis, DNA | |
dc.subject | Trans-Activators | |
dc.subject | Transcription Factors | |
dc.subject | Transcription, Genetic | |
dc.subject | Immunology and Infectious Disease | |
dc.title | ADA1, a novel component of the ADA/GCN5 complex, has broader effects than GCN5, ADA2, or ADA3 | |
dc.type | Journal Article | |
dc.source.journaltitle | Molecular and cellular biology | |
dc.source.volume | 17 | |
dc.source.issue | 6 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/infdis_pp/22 | |
dc.identifier.contextkey | 1088919 | |
html.description.abstract | <p>The ADA genes encode factors which are proposed to function as transcriptional coactivators. Here we describe the cloning, sequencing, and initial characterization of a novel ADA gene, ADA1. Similar to the previously isolated ada mutants, ada1 mutants display decreases in transcription from various reporters. Furthermore, ADA1 interacts with the other ADAs in the ADA/GCN5 complex as demonstrated by partial purification of the complex and immunoprecipitation experiments. We estimate that the complex has a molecular mass of approximately 2 MDa. Previously, it had been demonstrated that ada5 mutants displayed more severe phenotypic defects than the other ada mutants (G. A. Marcus, J. Horiuchi, N. Silverman, and L. Guarente, Mol. Cell. Biol. 16:3197-3205, 1996; S. M. Roberts and F. Winston, Mol. Cell. Biol. 16:3206-3213, 1996). ada1 mutants display defects similar to those of ada5 mutants and different from those of the other mutants with respect to promoters affected, inositol auxotrophy, and Spt- phenotypes. Thus, the ADAs can be separated into two classes, suggesting that the ADA/GCN5 complex may have two separate functions. We present a speculative model on the possible roles of the ADA/GCN5 complex.</p> | |
dc.identifier.submissionpath | infdis_pp/22 | |
dc.contributor.department | Department of Medicine, Division of Infectious Diseases and Immunology | |
dc.source.pages | 3220-8 |